IHEEZO DIN 02568330
Health Canada record
| Active ingredient(s) | CHLOROPROCAINE HYDROCHLORIDE 3 % |
|---|---|
| Dosage form | Gel |
| Route | Ophthalmic |
| Schedule | ETHICAL |
| Class | Human |
| ATC | S01HA08 CHLOROPROCAINE |
| Original market date | |
| Current status date | 14-May-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CHLOROPROCAINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02551063 | CLOROTEKAL | B. BRAUN MELSUNGEN AG | Solution | CHLOROPROCAINE HYDROCHLORIDE 10 MG | Marketed |
| 00613304 | NESACAINE CE 2% INJ 20MG/ML | ASTRAZENECA CANADA INC | Solution | CHLOROPROCAINE HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 00613312 | NESACAINE CE 3% INJ 30MG/ML | ASTRAZENECA CANADA INC | Solution | CHLOROPROCAINE HYDROCHLORIDE 30 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37565 | 2026-05-14 | New Drug Submission (NDS) |
International API supply for CHLOROPROCAINE HYDROCHLORIDE
3 active FDA Drug Master Files.
Request a quote for IHEEZO